NV Remedies Private Limited — Oxaliplatin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Oxaliplatin · $651.6K export value · DGFT Verified
NV Remedies Private Limited is the #11 Indian exporter of Oxaliplatin with $651.6K in export value and 16 verified shipments. NV Remedies Private Limited holds a 1.4% market share in Oxaliplatin exports across 4 countries. The company exports 15 pharmaceutical products worth $4.8M across 4 therapeutic categories.
NV Remedies Private Limited — Oxaliplatin Export Profile: Buyers & Destinations
Where Does NV Remedies Private Limited Export Oxaliplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UKRAINE | $200.3K | 8 | 48.7% |
| POLAND | $180.4K | 6 | 43.8% |
| KYRGHYSTAN | $17.9K | 1 | 4.4% |
| CONGO | $13.1K | 1 | 3.2% |
NV Remedies Private Limited exports Oxaliplatin to 4 countries. The largest destination is UKRAINE accounting for 48.7% of NV Remedies Private Limited's Oxaliplatin shipments, followed by POLAND (43.8%) and KYRGHYSTAN (4.4%). These destinations reflect NV Remedies Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Oxaliplatin from NV Remedies Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CPC "BIOCON" LLC | UKRAINE | $280.7K | 12 |
| CPC BIOCON LLC | UKRAINE | $100.0K | 2 |
| KYRGYZPHARMACY | KYRGHYSTAN | $17.9K | 1 |
| CENTRE NATIONAL DE LUTTE CONTRE LE | CONGO | $13.1K | 1 |
NV Remedies Private Limited supplies Oxaliplatin to 4 buyers globally. The largest buyer is CPC "BIOCON" LLC (UKRAINE), followed by CPC BIOCON LLC (UKRAINE) and KYRGYZPHARMACY (KYRGHYSTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Oxaliplatin Export Value and How Much Does NV Remedies Private Limited Contribute?
India exported $32.6M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. NV Remedies Private Limited contributes $651.6K to this total, accounting for 1.4% of India's Oxaliplatin exports. NV Remedies Private Limited ships Oxaliplatin to 4 countries through 4 buyers.
What Is the Average Shipment Value for NV Remedies Private Limited's Oxaliplatin Exports?
NV Remedies Private Limited's average Oxaliplatin shipment value is $40.7K per consignment, based on 16 shipments totaling $651.6K. The largest destination is UKRAINE (48.7% of NV Remedies Private Limited's Oxaliplatin exports).
How Does NV Remedies Private Limited Compare to Other Indian Oxaliplatin Exporters?
NV Remedies Private Limited ranks #11 among 249 Indian Oxaliplatin exporters with a 1.4% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($16.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.6M), ACCURE LABS PRIVATE LIMITED ($2.6M). NV Remedies Private Limited processed 16 shipments to 4 destination countries.
What Oxaliplatin Formulations Does NV Remedies Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OXOL SOLUTION FOR INJECTION 100MG/50ML OXALIPLATIN SOLUTION FOR INJECTION 100 MG/50ML 1ML CONTAINS:OXALIPLATIN USP 2 MG | $113.0K | 3 |
| OXOL SOLUTION FOR INJECTION 50MG/25ML OXALIPLATIN SOLUTION FOR INJECTION 50MG/25ML,1ML SOLUTION CON:OXALIPLATIN USP 2 MG | $67.4K | 3 |
| OXOL 100MG/50ML OXALIPLATIN SOLUTION FOR | $50.0K | 1 |
| OXOL 50MG/25ML OXALIPLATIN SOLUTION FOR | $50.0K | 1 |
| OXOL SOLUTION FOR INJECTION 50MG/25ML OXALIPLATIN SOLUTION FOR INJ. 50MG/25ML 1ML SOLUTION CONT: OXALIPLATIN USP 2MG | $50.0K | 1 |
| OXOL SOLUTION FOR INJECTION 100MG/50ML OXALIPLATIN SOLUTION FOR INJ. 100MG/50ML1ML SOLUTION CONT: OXALIPLATIN USP 2MG | $50.0K | 1 |
| OXALIPLATIN-MILI SOLUTION FOR INJ. OXALIPLATIN SOL. FOR INF. 100 MG/50ML. BN.X4AOX022A MD.01/2024 ED.12/2025 | $17.9K | 1 |
| OXALIPLATIN-MILI 100MG/50ML OXALIPLATININJ. USP100MG/50ML.EACH ML CONT:OXALIPLATIN USP 2MG(100MG/50ML VLS. | $13.1K | 1 |
| OXALIPLATIN WORKING STANDARD NO : WS/01 | $330 | 4 |
NV Remedies Private Limited exports 9 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OXOL SOLUTION FOR INJECTION 100MG/50ML OXALIPLATIN SOLUTION with 3 shipments worth $113.0K.
How Does NV Remedies Private Limited Compare to Nearest Oxaliplatin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED | $850.0K | 17 | 10 | $50.0K |
| 10 | INTAS PHARMACEUTICALS LIMITED | $790.8K | 32 | 6 | $24.7K |
| 11 | NV REMEDIES PRIVATE LIMITED ★ | $651.6K | 16 | 4 | $40.7K |
| 6 | MYLAN LABORATORIES LIMITED | $600.0K | 12 | 1 | $50.0K |
| 14 | CELON LABORATORIES PRIVATE LIMITED | $558.4K | 46 | 14 | $12.1K |
NV Remedies Private Limited ranks #11 among 249 Indian Oxaliplatin exporters. Average shipment value of $40.7K compared to the market average of $130.9K. The closest competitors by value are ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Oxaliplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 535 | 17.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 453 | 14.7% |
| DELHI AIR | 436 | 14.2% |
| SAHAR AIR | 410 | 13.3% |
| CHAWAPAYAL ICD (INCPR6) | 110 | 3.6% |
| Bombay Air | 108 | 3.5% |
| NHAVA SHEVA SEA (INNSA1) | 97 | 3.1% |
| CHAWAPAYAL ICD | 95 | 3.1% |
What Other Advanced Oncology Products Does NV Remedies Private Limited Export?
NV Remedies Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About NV Remedies Private Limited
NV Remedies Private Limited exports 15 products worth $4.8M. Beyond Oxaliplatin, top products include Docetaxel, Carboplatin, Paclitaxel, Chlorpheniramine, Fluorouracil. View the complete NV Remedies Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: NV Remedies Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 16 individual customs records matching NV Remedies Private Limited exporting Oxaliplatin, covering 9 formulations to 4 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Export Data from NV Remedies Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for NV Remedies Private Limited's Oxaliplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NV Remedies Private Limited
Full Company Profile →
15 products · $4.8M total trade · 4 categories
Oxaliplatin Stats
Company Overview
Top Products by NV Remedies Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for NV Remedies Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current shipment-level data, contact TransData Nexus.